TNFSF10 and Burkitt lymphoma: To mimic more closely the situation in patients, we delivered Jurkat-TRAIL cells when the tumours reached sizes of already 100 up to 1000 mm3, and found a reduction in growth of Burkitt lymphomas in either case.